In order to give you better service we use cookies. By continuing to browse the site you are agreeing to our use of cookies.
Lobular hyperplasia with invasive lobular carcinom

p120 + E-cadherin 6.0 mL

BC-API3011DSAA
Description
Specifications  
Intended Use
Source , 
Species Reactivity , 
Clone , 
Isotype , 
Antigen , 
Cellular Localization , 
Positive Control
Normal Tissue
Abnormal Tissue
LC/DC makes it much easier to identify the presence and the extent of the lobular lesions due to its bright pink color in lobular lesions, and therefore may provide a more accurate diagnosis. Diagnostic reproducibility of lobular versus ductal lesions, based on histology alone, is less than optimal. The proper distinction between atypical lobular hyperplasia, lobular carcinoma in situ and low-grade ductal carcinoma in situ is critical for patient management. E-cadherin, a negative membrane marker for lobular neoplasia, is useful in the distinction of ductal neoplasia vs. lobular; however as a negative marker for lobular carcinoma, it can be difficult to interpret, particularly in challenging cases. Studies have shown accurate categorization of ductal vs. lobular neoplasia in the breast with a combination of p120 + E-cadherin and helped give further clarification in the separation of low-grade ductal carcinoma in situ from lobular neoplasia. Of other tumors that may morphologically mimic lobular carcinoma, diffusely infiltrating variants of rectal and gastric carcinomas have shown diffuse cytoplasmic p120 immunostaining. In conclusion, this Multiplex IHC stain makes it much easier to identify the presence and the extent of the lobular lesions due to its bright pink color in lobular lesions, and therefore may provide a more accurate diagnosis.
Start > Finland E-line > Immunohistokemia > Multipleksit > p120 + E-cadherin 6.0 mL
Ads